© 2020 MJH Life Sciences and Patient Care Online. All rights reserved.
© 2020 MJH Life Sciences™ and Patient Care Online. All rights reserved.
June 17, 2019
ADA 2019-Dapagliflozin reduced CV death, hospitalization for HF, and progression of CKD among T2DM patients with a wide distribution of baselines CVD risk in DECLARE-TIMI 58.
September 12, 2016
Four studies presented at PAINWeek 2016 review the success of abuse-deterrent opioid formulations in stemming abuse and non-medical use.
September 27, 2011